investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Mechanisms of Non-Classical Multidrug Resistance in Cancer
Michael Gottesman
2 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
No posts
Related projects
Elliot Chaikof
A PSGL-1 Glycopeptide Mimetic for Treatment of Venous Thromboembolism
All cancers but non-melanoma skin cancer
Nicholas Restifo
Building on the Success of the Adoptive Immunotherapy of Cancer
All cancers but non-melanoma skin cancer
Boussiotis Vassiliki A
Effects of PGE2 on Reconstitution of Hematopoiesis and Immunity after UCBT
All cancers but non-melanoma skin cancer
Aimin Jiang
b-catenin in vaccine-induced anti-tumor CD8 T cell immunity
All cancers but non-melanoma skin cancer
Kyung Lee
Molecular Basis of Centreiole Duplication
All cancers but non-melanoma skin cancer
Wenyi Wang
Statistical methods for genomic analysis of heterogeneous tumors
All cancers but non-melanoma skin cancer
Ira Pastan
Development of Improved Mesothelin Targeted Immunotoxins and other Tumor Specific Targeted Immunotoxins Using Proprietary Targeting Moieties
All cancers but non-melanoma skin cancer
Ronglai Shen
Defining a novel subtype of luminal-TP53 mutant breast cancer with poor prognosis
All cancers but non-melanoma skin cancer
Eric Batchelor
Systems-Level Analysis of the Regulation and Function of p53 Dynamics
All cancers but non-melanoma skin cancer